Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02964312 · ClinicalTrials.gov registry record · NA
LATERA-OFFICE Study
A NA study, sponsored by Spirox.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT02964312 is a NA study that has completed, run by Spirox. The registered enrollment target is 166 participants.
The verdict
NCT02964312, a NA study, has completed, sponsored by Spirox.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
Prospective, multicenter, nonrandomized, single-arm controlled study to obtain outcomes data in participants with severe to extreme class NOSE scores who are undergoing placement of the Spirox Latera Implant with or without concurrent turbinate reduction procedures in an office setting.
Interventions
- DEVICE Nasal Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2016-11-10 |
| Est. Completion | 2019-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02964312
The ClinicalTrials.gov registry entry for NCT02964312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spirox, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nasal Implant is the first listed.
NCT02964312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02964312 about?
NCT02964312 is a clinical study titled "LATERA-OFFICE Study". Prospective, multicenter, nonrandomized, single-arm controlled study to obtain outcomes data in participants with severe to extreme class NOSE scores who are undergoing placement of the Spirox Latera Implant with or without concurrent turbinate reduction procedures in an office setting.
What is the current status of trial NCT02964312?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2016-11-10. Estimated completion is 2019-08-29.
What interventions are being tested in trial NCT02964312?
The interventions under investigation include: Nasal Implant (DEVICE).
Who is sponsoring clinical trial NCT02964312?
This trial is sponsored by Spirox, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.